Acvybra
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Acvybra, covering 2026-02-24 to 2026-07-14. Get the full timeline:
Most recent: EMA Authorised: Acvybra (denosumab) — Reddy Holding GmbH
2 regulatory and trial events tracked for Acvybra, covering 2026-02-24 to 2026-07-14. Get the full timeline:
Most recent: EMA Authorised: Acvybra (denosumab) — Reddy Holding GmbH